About this trial
The goal of this study is to develop a real-time artificial intelligence-driven 3D kidney model to assist robotic or laparoscopic partial nephrectomy:
• Can this AI-powered model optimize the workflow of partial nephrectomy and enhance surgical benefits?
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Ages 18-80 years, regardless of gender
Written informed consent obtained from the patient or legally authorized representative after full protocol disclosure
Preoperative imaging (CT/MRI) confirming clinical stage T1a or select T1b renal tumors suitable for partial nephrectomy (R.E.N.A.L. nephrometry score ≤10)
Localized renal tumors without lymph node/distant metastasis per NCCN Guidelines® (v2023)
Disqualifiers
Multifocal renal tumors (bilateral or unilateral)
Prior systemic anticancer therapy (targeted agents/immunotherapy/chemotherapy) within 6 months
Absolute surgical contraindications (e.g., ASA class ≥IV, uncontrolled coagulopathy)
Intraoperative conversion to radical nephrectomy or open approach
Trial design
Parallel
Treatments tested in this trial
an AI-based real-time image-guided kidney model system
Procedure/SurgeryUse the AI-model to locate kidney and tumour, assisting surgeon with the operation
Treatment groups
Trial outcomes
Primary outcomes
Operative Time
Secondary outcomes
Operating Surgeon's Assessment
Scoring for Each Surgery(0-5) by navigation accuracy, image rendering smoothness
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Shao Pengfei
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University
Sponsor institution
Southeast University, China
Collaborator